mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |